Relationship between plasma asymmetrical dimethylarginine and coronary artery disease

National Medical Journal of China

Volumn 87, Issue 22, 2007, Pages 1527-1530

  Song, Ying ^a   Qu, Xiu Fen ^a   Yu, Yan Wei ^a   Luan, Tian Zhu ^a   Li, Jing Jie ^a   Guo, Hong ^a   Yu, Yang ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Asymmetrical dimethylarginine; Coronary artery disease; Nitric oxide synthase

Indexed keywords

CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; NITRATE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; COLORIMETRY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATHOGENESIS; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ARGININE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 34548241243     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol, 2000, 20: 2032-2037.
2. Miyazaki H, Matsuoka H, Cooke JP, et al. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation, 1999, 99: 1141-1146.
3. Vallance P, Leone A, Calver A, et al. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet, 1992,339:572-575.
4. Fickling S, Leone A, Nussey S, et al. Synthesis of N, N- dimethylarginine by human endothelial cells. Endothelium, 1993, 1:137-140.
5. Lundman P, Eriksson NJ, Stuhlinger M, et al. Mild-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol, 2001,38:111-116.
6. Masuda H, Tamaoki S, Azuma H, et al. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br J Pharmacol, 1999,126:211-218.
7. Jason R, Chan H, Rainer H, et al. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol, 2000,20: 1040-1046.
8. Bogër RH, Bode-Bogër SM, Tsao PS, et al. An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol, 2000,36:2287-2295.
9. Bode-Bogër SM, Bogër RH, Kienke S, et al. Elevated L-arginine/ dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun, 1996,219:598-603.
10. Xiong Y, Li YJ, Yu XJ, et al. Endogenous inhibitor of nitric oxide synthesis and lipid peroxidation in hyperlipidomic rabbits. Acta Pharmacolsin, 1996,17: 149-152.
11. Bogër RH, Sydow K, Borlak J, et al. Cholesterol upregulates synthesis of asymmetric dimethylarginine (ADMA) in human endothelial cells. Involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res, 2000,87:99-105.